Actively Recruiting
Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain
Led by Erchonia Corporation · Updated on 2025-09-08
32
Participants Needed
1
Research Sites
110 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this clinical study is to determine the effectiveness of the Erchonia® EVRL™, manufactured by Erchonia Corporation (the Company), in providing prescription home use application for temporary relief of idiopathic neuropathy foot pain in individuals diagnosed with idiopathic neuropathy by a suitably qualified and licensed health professional.
CONDITIONS
Official Title
Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Previously diagnosed with idiopathic peripheral neuropathy by a licensed health professional within the past 6 months
- Over 22 years of age
- Able to read and write English
- Constant foot pain ongoing for at least the past 3 months
- On a stable pain medication regimen for at least 14 days prior to enrollment, with no planned increases during the study
- Willing to avoid non-study therapies for foot pain during participation
- Willing to avoid pain medication for at least 6 hours before scheduled pain ratings
- Foot pain rating of 50 or greater on a 0-100 visual analog scale
You will not qualify if you...
- Diagnosed with diabetes (hemoglobin A1c of 6.5% or higher)
- Diagnosed with a known cause of peripheral neuropathy other than idiopathic within the past 6 months
- Pregnant, breastfeeding, or planning pregnancy during the study
- Presence of open wounds, sores, cuts, or ulcers on or around the feet
- Presence of cancerous growths or lesions on or around the feet
- Difficulty with hand dexterity that affects ability to use the laser device, such as severe arthritis, Multiple Sclerosis, Cerebral Palsy, Parkinson's Disease, or Huntington's Disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Franco & Co
Miramar, Florida, United States, 33025
Actively Recruiting
Research Team
T
Travis Sammons
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here